May 14, 2015
Baylor‘s Human Genome Sequencing Center will help Mayo Clinic sequence the DNA of Mayo biobank members for 69 different genes that can influence how patients’ metabolize or react to different drugs.
The goal is to determine which “pharmacogenomic” findings are relevant to the individual patient and to insert that information into their medical records – providing an “early warning system” to prevent adverse drug reactions or ineffective treatments.
› Read BCM's Momentum blog story
› Read news release from Mayo Clinic